Breaking News

BioScreen Completes FDA Inspection

July 8, 2014

Inspection covered quality system and lab facilities in Torrance, CA

BioScreen Testing Services, Inc. has successfully completed an FDA audit of their lab facility in Torrance, CA, with no 483 citations issued. The inspection covered BioScreen’s quality system as well as all lab facilities, and expanded chemistry and microbiology labs. 
 
"The results from the FDA audit are extremely positive and serve as a testament to the high Quality Standards that BioScreen sets for itself," said Ranil M. Fernando, executive vice president of BioScreen.
 
BioScreen's President, Bradford Rope added, "We are extremely pleased to share this news

blog comments powered by Disqus
  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • CMOs: A Flexibility Alternative

    CMOs: A Flexibility Alternative

    Philip K. Burns, CRO-Consulting||January 28, 2016
    A look at how to include CMOs as an option to improve overall flexibility